Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease
Ashwani K Singal1, Shannon M Bailey2
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
Alcohol-associated liver disease (AALD) involves immune cell dysfunction, leading to inflammation and organ damage. Emerging blood cell biomarkers show promise for diagnosing and predicting AALD and alcoholic hepatitis (AH).
Area of Science:
- Immunology
- Hepatology
- Toxicology
Background:
- Alcohol-associated liver disease (AALD) is a leading cause of mortality and morbidity in the US.
- Alcoholic hepatitis (AH) significantly contributes to liver disease admissions and transplants.
- Peripheral blood cells play a critical role in the systemic pathology of AALD and AH.
Purpose of the Study:
- To review the disruptive effects of alcohol on innate and adaptive immune cells in AALD and AH.
- To highlight emerging cellular biomarkers for diagnosing and prognosing AALD and AH.
Main Methods:
- Review of existing literature on alcohol's impact on immune cell function.
- Analysis of how alcohol affects lymphocytes, neutrophils, monocytes, and macrophages.
- Focus on cellular mechanisms contributing to inflammation, oxidative stress, and fibrosis.
Main Results:
- Alcohol consumption dysregulates the function of key innate immune cells.
- These immune cell alterations impact adaptive immune responses.
- Peripheral blood cells are implicated in systemic inflammation, oxidative stress, mitochondrial dysfunction, and fibrosis.
Conclusions:
- Immune cell dysfunction is central to the pathogenesis of AALD and AH.
- Cellular-based biomarkers derived from peripheral blood offer potential for improved diagnosis and prognosis.
- Further research into these biomarkers could advance AALD and AH patient management.
Abstract:
Alcohol-associated liver disease (AALD) is the third most common preventable cause for disease burden and mortality in the US. AALD, including alcoholic hepatitis (AH), contributes to half of admissions from decompensated liver disease and 20% of all liver transplants in the US. Peripheral blood cells contribute to systemic inflammation, oxidative stress, mitochondrial dysfunction, and fibrosis in AALD and AH. Alcohol dysregulates function of lymphocytes, neutrophils, monocytes, and tissue macrophages of the innate immune system. These alterations in turn can modulate adaptive immune responses. In this review, we describe these disruptive effects of alcohol on cells of the innate and adaptive immune system and focus on cellular-based emerging biomarkers on diagnosis and prognosis of patients with AALD and AH.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Abnormal Proliferation
Emerging Adulthood
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Introduction Cardiac Emergencies
Oxidation of Alcohols
The process of oxidation in a chemical reaction is observed in any of the three forms:
